Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer

被引：0
|
作者：
Kurozumi, Sasagu [1 ]
Green, Andrew R. [1 ]
Ellis, Ian O. [1 ]
Rakha, Emad A. [1 ]
Fujii, Takaaki [2 ]
Shirabe, Ken [2 ]
Heery, David [3 ]
Zwart, Wilbert [4 ]
Oesterreich, Steffi [5 ,6 ]
Johnston, Simon J. [1 ]
机构：
[1] Univ Nottingham, Nottingham Breast Canc Res Ctr, Nottingham, England
[2] Gunma Univ, Dept Gen Surg Sci, Grad Sch Med, Gunma, Japan
[3] Univ Nottingham, Sch Pharm, Gene Regulat Lab, Nottingham, England
[4] Netherlands Canc Inst, Amsterdam, Netherlands
[5] UPMC Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA USA
[6] Magee Women Res Inst, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P1-18-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-18-06
引用
收藏
页数：2
相关论文
共 50 条
  • [41] DNA sequencing of the small bowel adenocarcinomas to identify targetable ErbB2 mutations.
    Adam, Liana
    Fowler, Jerry
    Wu, Wenhui
    Yu, Yao
    Wang, Huamin
    Lucas, Francis A. San
    Huff, Chad
    Kopetz, Scott
    Scheet, Paul
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] ErbB2 immune response in breast cancer patients with soluble receptor ectodomain
    Visco, V
    Bei, R
    Moriconi, E
    Gianni, W
    Kraus, MH
    Muraro, R
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04): : 1417 - 1424
  • [43] Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
    Marotta, Michael
    Onodera, Taku
    Johnson, Jeffrey
    Budd, G. Thomas
    Watanabe, Takaaki
    Cui, Xiaojiang
    Giuliano, Armando E.
    Niida, Atsushi
    Tanaka, Hisashi
    SCIENTIFIC REPORTS, 2017, 7
  • [44] Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers
    Mungamuri, Sathish Kumar
    Murk, William
    Grumolato, Luca
    Bernstein, Emily
    Aaronson, Stuart A.
    CELL REPORTS, 2013, 5 (02): : 302 - 313
  • [45] Morphologic and genomic characterization of circulating tumor cells in patients with ERBB2 mutant HER2 non-amplified metastatic breast cancer treated with neratinib
    Shishido, Stephanie Nicole
    Masson, Rahul
    Welter, Lisa
    Xu, Liya
    D'Souza, Anishka
    Spicer, Darcy
    Hicks, James
    Lu, Janice
    Kuhn, Peter
    CANCER RESEARCH, 2019, 79 (13)
  • [46] Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib.
    D'souza, Anishka
    Shishedo, Stephanie
    Spicer, Darcy V.
    Welter, Lisa
    Jiang, Yuanfei
    Hyman, David Michael
    Solit, David B.
    Ma, Cynthia X.
    Bose, Ron
    Cutler, Richard E.
    Eli, Lisa
    Hicks, James B.
    Kuhn, Peter
    Lu, Janice M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With ERBB2 Amplification or ERBB2/3 Mutations: Results From the TAPUR Study
    Gupta, Ranju
    Meric-Bernstam, Funda
    Rothe, Michael
    Garrett-Mayer, Elizabeth
    Mangat, Pam K.
    D'Andre, Stacy
    Ahn, Eugene R.
    O'Lone, Raegan
    Halabi, Susan
    Grantham, Gina N.
    Schilsky, Richard L.
    JCO PRECISION ONCOLOGY, 2022, 6
  • [48] Clinical and genomic landscape of ERBB2 and ERBB3 mutated breast cancer
    Bilani, Nadeem
    Tao, Jacqueline
    Safonov, Anton
    Casey, Dana
    Drago, Joshua
    Ahmed, Mehnaj
    Acevedo, Barbara
    Jhaveri, Komal
    Reis-Filho, Jorge
    Robson, Mark
    Toska, Eneda
    Hanker, Ariella
    Arteaga, Carlos
    Chandarlapaty, Sarat
    Wen, Hanna Y.
    Razavi, Pedram
    CANCER RESEARCH, 2024, 84 (09)
  • [49] ERBB2 AMPLIFICATION IS ASSOCIATED WITH TAMOXIFEN RESISTANCE IN STEROID-RECEPTOR POSITIVE BREAST-CANCER
    BORG, A
    BALDETORP, B
    FERNO, M
    KILLANDER, D
    OLSSON, H
    RYDEN, S
    SIGURDSSON, H
    CANCER LETTERS, 1994, 81 (02) : 137 - 144
  • [50] The ErbB2 signaling network as a target for breast cancer therapy
    Badache, Ali
    Goncalves, Anthony
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2006, 11 (01) : 13 - 25
12345